Merck & Co., Drugmaker | featured news

merck & co., drugmaker
(Image from article: "Merck to buy Schering-Plough in $41.1 billion deal")

Welcome to Wopular's coverage of Merck & Co., Drugmaker. Wopular aggregates news headlines from the top newspapers and news sources. To the right are articles about Merck & Co., Drugmaker that have been featured on main sections of the site.

Below are topics about Merck & Co., Drugmaker. (Click on "all" to view all articles related to the topic, including articles NOT about Merck & Co., Drugmaker.

Click here to search news sites, aggregators, and blogs as well as videos, photos, and websites about Merck & Co., Drugmaker.

Bookmark or Share

Main Topics

Drugmaker Topics

Merck ponders next step for troubled heart drug

Officials at drugmaker Merck & Co. say they will take more time to decide what to do about an experimental blood thinner that gave disappointing results in a second big study....

 

Merck to pay nearly $1 billion to settle U.S. charges

Merck to pay nearly $1 billion to settle U.S. charges

Merck & Co will pay roughly $950 million to settle criminal and civil charges that it promoted the painkiller drug Vioxx for an unapproved use, the U.S. Justice Department said on Tuesday.

 

Merck to buy Schering-Plough in $41.1 billion deal

Merck to buy Schering-Plough in $41.1 billion deal

Drugmakers Merck & Co. and Schering-Plough Corp. are planning to merge under the name Merck in a stock-and-cash deal worth about $41.1 billion.

 

Subscribe to this RSS topic: Syndicate content